Financials

  • Market Capitalization 1.11 M
  • Employee 13
  • Founded 2008
  • CEO N/A
  • Website silexion.com
  • Headquarter Cayman Islands
  • FIGI N/A
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
0.21
Price to sales ratio
75.76

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5131
PPBT
Purple Biotech Ltd - American Depositary Shares
1.50 USD+4.90%-4.46%-7.41%+158.62%1.39 M USD
5140
JAGX
Jaguar Health, Inc. - Common Stock
1.80 USD-7.22%-21.74%-21.74%+190.32%1.09 M USD
5157
ONCO
Onconetix, Inc. - Common Stock
0.76 USD-1.30%-20.83%-25.49%0.00%871.31 K USD
5158
SCNI
Scinai Immunotherapeutics Ltd - American Depositary Shares
0.26 USD0.00%0.00%-25.71%-65.62%901.74 K USD

Frequently asked questions about Silexion Therapeutics Corp - Ordinary Shares

What is the Silexion Therapeutics Corp - Ordinary Shares stock price today?

The current price of Silexion Therapeutics Corp - Ordinary Shares (SLXN) is 2.65. Over the past 24 hours, the stock has changed by +3.92%. Follow the SLXN chart for real-time price dynamics.

What is the stock ticker of Silexion Therapeutics Corp - Ordinary Shares?

Silexion Therapeutics Corp - Ordinary Shares trades under the ticker SLXN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silexion Therapeutics Corp - Ordinary Shares stock going up?

SLXN has changed by +4.74% over the last week, -0.75% over the last month, and +64.60% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Silexion Therapeutics Corp - Ordinary Shares net income for the last quarter?

Silexion Therapeutics Corp - Ordinary Shares reported net income of -2.73 M for the last quarter. The previous quarter showed -4.41 M, which means net income changed by +38.06%.

How many employees does Silexion Therapeutics Corp - Ordinary Shares have?

As of the latest available data, Silexion Therapeutics Corp - Ordinary Shares has 13 employees. Workforce size can provide additional context about the company's scale and operations.

What is Silexion Therapeutics Corp - Ordinary Shares EBITDA?

Silexion Therapeutics Corp - Ordinary Shares EBITDA is -2.74 M, and its EBITDA margin is -10.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Silexion Therapeutics Corp - Ordinary Shares stock?

You can buy Silexion Therapeutics Corp - Ordinary Shares (SLXN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silexion Therapeutics Corp - Ordinary Shares stock?

Investing in Silexion Therapeutics Corp - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLXN chart and related analysis on metatrader.com as part of your research.